Evidence map›Paper›PMID 36658365›Full record

Trial reportHuman genetics2023

Target-allele-specific probe single-base extension (TASP-SBE): a novel MALDI-TOF-MS strategy for multi-variants analysis and its application in simultaneous detection of α-/β-thalassemia mutations.

Qiong Chen, Xuexi Yang, Weilun Huang, Ziyan Li, Mingli Xu, Yang Li, Fangchao Tao, Zhengyi Huang, Xu Yang, Xuefeng Zhao and 2 more

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Human genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Qiong Chen *Medical Research Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xuexi Yang *Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Weilun HuangDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Ziyan LiDepartment of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Mingli XuDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Yang LiDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Fangchao TaoDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Zhengyi HuangDepartment of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Xu YangGuangzhou Darui Biotechnology Co., Ltd., Guangzhou, China.
Xuefeng ZhaoDepartment of Laboratory Medicine, Guangming Maternal and Child Health Hospital, Shengzhen, China.
Linxiao JiangDepartment of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China. jiang-lingxiao@163.com.
Wanjun ZhouDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. zhouwanjun72@163.com.ORCID http://orcid.org/0000-0002-0760-9041
Southern Medical University · CNZhujiang Hospital · CNNanfang Hospital · CN

Funding

Basic and Applied Basic Research Foundation of Guangdong Province 2021A1515012585Guangming Soft Science Research Project of Shenzhen 2021R01098National Natural Science Foundation of China 81972008
6 · The paper itself

Abstract

Single-nucleotide variants (SNVs) and copy number variations (CNVs) are the most common genomic variations that cause phenotypic diversity and genetic disorders. MALDI-TOF-MS is a rapid and cost-effective technique for multi-variant genotyping, but it is challenging to efficiently detect CNVs and clustered SNVs, especially to simultaneously detect CNVs and SNVs in one reaction. Herein, a novel strategy termed Target-Allele-Specific Probe Single-Base Extension (TASP-SBE) was devised to efficiently detect CNVs and clustered SNVs with MALDI-TOF-MS. By comprehensive use of traditional SBE and TASP-SBE strategies, a MALDI-TOF-MS assay was also developed to simultaneously detect 28 α-/β-thalassemia mutations in a single reaction system, including 4 α-thalassemia deletions, 3 HBA and 21 HBB SNVs. The results showed that all 28 mutations were sensitively identified, and the CNVs of HBA/HBB genes were also accurately analyzed based on the ratio of peak height (RPH) between the target allele and reference gene. The double-blind evaluation results of 989 thalassemia carrier samples showed a 100% concordance of this assay with other methods. In conclusion, a one-tube MALDI-TOF-MS assay was developed to simultaneously genotype 28 thalassemia mutations. This novel TASP-SBE was also verified a practicable strategy for the detection of CNVs and clustered SNVs, providing a feasible approach for multi-variants analysis with MALDI-TOF-MS technique.

Indexed as

beta-ThalassemiaThalassemiaAllelesDNA Copy Number VariationsHumansMutationSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Identifiers

PMID36658365
OpenAlexW4317473215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.